We are live on ! Find out more
KAM

Kazazian Asset Management Portfolio holdings

AUM $91.5M
1-Year Est. Return 35.36%
This Fund
S&P 500
This Quarter Est. Return
-4.16%
1 Year Est. Return
+35.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$74.1M
AUM Growth
-$10.3M
Cap. Flow
-$2.16M
Cap. Flow %
-2.91%
Top 10 Hldgs %
58.8%
Holding
70
New
3
Increased
9
Reduced
9
Closed
12

Top Buys

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$2.07M
2
FDX icon
FedEx
FDX
+$1.92M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$994K
4
PCG icon
PG&E
PCG
+$771K
5
I
INTELSAT S. A.
I
+$527K

Top Sells

Rank Stock Value
1
GREK
Global X MSCI Greece ETF
GREK
+$2.28M
2
BIDU icon
Baidu
BIDU
+$1.69M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$1.46M
4
ARGT icon
Global X MSCI Argentina ETF
ARGT
+$814K
5
PVTL
Pivotal Software, Inc.
PVTL
+$535K

Sector Composition

Rank Sector Weight
1 Financials 16.97%
2 Communication Services 14.8%
3 Healthcare 11.83%
4 Industrials 7.77%
5 Consumer Discretionary 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
26
Bristol-Myers Squibb
BMY
$132B
$731K 0.99%
14,424
– –
CS
27
DELISTED
Credit Suisse Group
CS
$701K 0.95%
57,451
– –
PCG icon
28
PG&E
PCG
$38.5B
$675K 0.91%
67,459
+51,000
+310% +$771K
SAIL
29
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$648K 0.88%
34,695
-10,000
-22% -$212K
I
30
DELISTED
INTELSAT S. A.
I
$570K 0.77%
+25,000
New +$527K
ZUO
31
DELISTED
Zuora, Inc.
ZUO
$566K 0.76%
37,617
+7,500
+25% +$113K
BPMC
32
DELISTED
Blueprint Medicines
BPMC
$563K 0.76%
7,662
– –
DB icon
33
Deutsche Bank
DB
$71.5B
$473K 0.64%
63,000
– –
CCS icon
34
Century Communities
CCS
$2.03B
$459K 0.62%
14,977
– –
AUPH icon
35
Aurinia Pharmaceuticals
AUPH
$2.11B
$446K 0.6%
83,572
– –
VWO icon
36
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$382K 0.52%
9,480
– –
EWG icon
37
iShares MSCI Germany ETF
EWG
$1.62B
$346K 0.47%
12,845
-12,844
-50% -$345K
ZGNX
38
DELISTED
Zogenix, Inc.
ZGNX
$308K 0.42%
7,704
– –
CAAP icon
39
Corporacion America
CAAP
$4.09B
$305K 0.41%
+67,330
New +$428K
BLUE
40
DELISTED
bluebird bio
BLUE
$258K 0.35%
217
– –
CELG
41
DELISTED
Celgene Corp
CELG
$254K 0.34%
2,554
– –
V icon
42
Visa
V
$677B
$246K 0.33%
1,433
– –
WMB icon
43
Williams Companies
WMB
$86.1B
$227K 0.31%
9,445
– –
IBB icon
44
iShares Biotechnology ETF
IBB
$9.77B
$217K 0.29%
2,177
– –
NETI
45
DELISTED
Eneti Inc.
NETI
$205K 0.28%
3,620
-1,614
-31% -$90.6K
BCS icon
46
Barclays
BCS
$94.1B
$195K 0.26%
26,564
-560
-2% -$4.05K
AMRN
47
Amarin Corp
AMRN
$303M
$194K 0.26%
638
– –
SOHU
48
Sohu.com
SOHU
$357M
$163K 0.22%
+16,048
New +$189K
ET icon
49
Energy Transfer Partners
ET
$69.3B
$143K 0.19%
10,954
– –
KPTI icon
50
Karyopharm Therapeutics
KPTI
$48M
$124K 0.17%
858
– –
1
2
3

Similar funds

MRP
Measured Risk Portfolios San Diego, California $91.4M AUM 0.88% 1-Year Est. Return
ITG
Index Technologies Group New York $91.8M AUM
MA
Marquette Associates Chicago, Illinois $91.9M AUM 13.47% 1-Year Est. Return
AW
Aspirean Wealth Mill Valley, California $92.1M AUM
SPCM
Spruce Point Capital Management New York $90.9M AUM
ML
MLP3 LLC Linwood, New Jersey $90.7M AUM
ICM
Incision Capital Management San Francisco, California $90.6M AUM
ACMC
Anchor Capital Management Company Raleigh, North Carolina $92.7M AUM 19.36% 1-Year Est. Return

Kazazian Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, Kazazian Asset Management held 70 positions worth $74.1M, down 12% from $84.4M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Kazazian Asset Management's Q3 2019 filing shows 3 new, 9 increased, 9 reduced and 12 closed positions. Its largest new stake was INTELSAT S. A.: 25,000 shares worth $570K. The largest sale was Global X MSCI Greece ETF, an estimated $2.28M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 20% a quarter earlier, followed by Communication Services and Healthcare.

  • Kazazian Asset Management's largest Q3 2019 buy was INTELSAT S. A.: 25,000 shares worth $570K.
  • Kazazian Asset Management added most to Clovis Oncology, Inc. in Q3 2019, an estimated $2.07M increase.
  • Kazazian Asset Management's biggest Q3 2019 reduction was Global X MSCI Greece ETF, cutting an estimated $2.28M.
  • Kazazian Asset Management fully exited iShares MSCI Emerging Markets ETF in Q3 2019, selling an estimated $1.46M.
  • Kazazian Asset Management's ten largest holdings make up 59% of its $74.1M portfolio in Q3 2019.
  • Kazazian Asset Management opened 3 new positions and closed 12 in Q3 2019.
  • Kazazian Asset Management's portfolio value fell 12% quarter-over-quarter to $74.1M.

Based on Kazazian Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.